Aubert-Pouëssel Anne, Venier-Julienne Marie-Claire, Saulnier Patrick, Sergent Michelle, Benoît Jean-Pierre
INSERM U646, Ingénierie de la Vectorisation Particulaire, IBT, 10 rue André Boquel, 49 100 Angers, France.
Pharm Res. 2004 Dec;21(12):2384-91. doi: 10.1007/s11095-004-7693-3.
To develop biodegradable poly(lactic-co-glycolic acid) (PLGA) microparticles prepared by an original emulsion-extraction process, with glycofurol, a nontoxic excipient, as polymer solvent.
The preparation of microparticles consisted in dissolving polymer in glycofurol. This solution was emulsified in a vegetable oil, and then amphiphilic agent was added into the emulsion to extract glycofurol and lead to microparticle formation. Physicochemical studies were carried out, and an experimental design was prepared in order to elucidate the impact of the formulation composition on the microparticle characteristics. Finally, encapsulation tests were made with a model protein.
In a ternary diagram, a small feasibility area allowing particle formation was located. The resulting microparticles were spherical with a homogeneous, polymeric matrix structure. They exhibited a variable size from 3 to 15 microm, which was controlled by the different formulation parameters. Differential scanning calorimetry (DSC) analysis made it possible to detect their composition. Preliminary results showed that these particles were able to encapsulate a protein model, lysozyme.
This simple and convenient technique enabled us to obtain spherical, biodegradable microparticles from acceptable excipients. Moreover, the process conditions made possible the encapsulation of drugs, including proteins.
采用一种原始的乳液萃取工艺制备可生物降解的聚乳酸-乙醇酸共聚物(PLGA)微粒,使用无毒辅料二缩三丙二醇甲醚作为聚合物溶剂。
微粒的制备包括将聚合物溶解于二缩三丙二醇甲醚中。该溶液在植物油中乳化,然后向乳液中加入两亲性试剂以萃取二缩三丙二醇甲醚并导致微粒形成。进行了物理化学研究,并设计了一个实验方案以阐明配方组成对微粒特性的影响。最后,用一种模型蛋白进行了包封测试。
在三元相图中,确定了一个允许形成颗粒的小可行性区域。所得微粒呈球形,具有均匀的聚合物基质结构。它们的尺寸在3至15微米之间变化,这可通过不同的配方参数进行控制。差示扫描量热法(DSC)分析能够检测其组成。初步结果表明这些颗粒能够包封一种蛋白模型,即溶菌酶。
这种简单便捷的技术使我们能够从可接受的辅料中获得球形、可生物降解的微粒。此外,工艺条件使得包括蛋白质在内的药物包封成为可能。